Screening for Dysglycemia: Connecting Supply and Demand to Slow Growth in Diabetes Incidence

English version České info

Mohammed Ali and Venkat Narayan describe the challenge of implementing evidence-based interventions for prevention for the large number of people at increased risk of type 2 diabetes.

Vyšlo v časopise: Screening for Dysglycemia: Connecting Supply and Demand to Slow Growth in Diabetes Incidence. PLoS Med 13(7): e32767. doi:10.1371/journal.pmed.1002084
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002084

Souhrn

Mohammed Ali and Venkat Narayan describe the challenge of implementing evidence-based interventions for prevention for the large number of people at increased risk of type 2 diabetes.

Zdroje

1. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. Epub 2002/02/08. doi: 10.1056/NEJMoa012512 346/6/393 [pii]. 11832527; PubMed Central PMCID: PMC1370926.

2. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–544. Epub 1997/04/01. 9096977.

3. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–1350. Epub 2001/05/03. doi: 10.1056/NEJM200105033441801 11333990.

4. Ali MK, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff (Millwood). 2012;31(1):67–75. Epub 2012/01/11. doi: 10.1377/hlthaff.2011.1009 22232096.

5. Li R, Qu S, Zhang P, Chattopadhyay S, Gregg EW, Albright A, et al. Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med. 2015;163(6):452–460. doi: 10.7326/M15-0469 26167962.

6. U.S. Department of Health and Human Services. Independent experts confirm that diabetes prevention model supported by the Affordable Care Act saves money and improves health HHS.gov2016 [cited 2016 April 19]. http://www.hhs.gov/about/news/2016/03/23/independent-experts-confirm-diabetes-prevention-model-supported-affordable-care-act-saves-money.html.

7. Torjesen I. NHS England rolls out world’s first national diabetes prevention programme. BMJ. 2016;352. doi: 10.1136/bmj.i1669

8. Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract. 2007;78(3):305–312. Epub 2007/07/03. S0168-8227(07)00309-9 [pii] doi: 10.1016/j.diabres.2007.05.004 17601626.

9. International Diabetes Federation. IDF Diabetes Atlas 7th Edition Brussels, Belgium 2015 [cited 2016 April]. http://www.diabetesatlas.org/

10. Ali MK, Bullard KM, Gregg EW, Del Rio C. A cascade of care for diabetes in the United States: visualizing the gaps. Ann Intern Med. 2014;161(10):681–689. doi: 10.7326/M14-0019 25402511.

11. Li Y, Geiss LS, Burrows NR, Rolka DB, Albright A. Awareness of Prediabetes—United States, 2005–2010. Morbidity and Mortality Weekly. March 22, 2013;62(11):209–212.

12. Echouffo-Tcheugui JB, Ali MK, Griffin SJ, Narayan KM. Screening for type 2 diabetes and dysglycemia. Epidemiol Rev. 2011;33(1):63–87. Epub 2011/06/01. doi: 10.1093/epirev/mxq020 21624961.

13. Siu AL. Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus. Ann Intern Med. 2015;163(11):861–868. doi: 10.7326/M15-2345 26501513

14. American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2016;39(Supplement 1):S13–S22. doi: 10.2337/dc16-S005

15. Bullard KM, Ali MK, Imperatore G, Geiss LS, Saydah SH, Albu JB, et al. Receipt of Glucose Testing and Performance of Two US Diabetes Screening Guidelines, 2007–2012. PLoS ONE. 2015;10(4):e0125249. doi: 10.1371/journal.pone.0125249 25928306; PubMed Central PMCID: PMCPMC4416019.

16. Gregg EW, Sattar N, Ali MK. The changing face of diabetes complications. Lancet Diabetes Endocrinol. 4(6):537–547. doi: 10.1016/S2213-8587(16)30010-9 27156051

17. Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Aff (Millwood). 2008;27(3):759–769. doi: 10.1377/hlthaff.27.3.759 18474969.

18. Konchak JN, Moran MR, O’Brien MJ, Kandula NR, Ackermann RT. The State of Diabetes Prevention Policy in the USA Following the Affordable Care Act. Curr Diab Rep. 2016;16(6):1–12. doi: 10.1007/s11892-016-0742-6

19. Penn L, White M, Lindström J, den Boer AT, Blaak E, Eriksson JG, et al. Importance of Weight Loss Maintenance and Risk Prediction in the Prevention of Type 2 Diabetes: Analysis of European Diabetes Prevention Study RCT. PLoS ONE. 2013;8(2):e57143. doi: 10.1371/journal.pone.0057143 23451166

20. Geiss LS, Wang J, Cheng YJ, et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012. JAMA. 2014;312(12):1218–1226. doi: 10.1001/jama.2014.11494 25247518

21. Gregg EW, Zhuo X, Cheng YJ, Albright AL, Narayan KM, Thompson TJ. Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985–2011: a modelling study. Lancet Diabetes Endocrinol. 2014;2(11):867–874. doi: 10.1016/S2213-8587(14)70161-5 25128274.

22. Centers for Disease Control and Prevention. Diabetes Prevention Recognition Program: Standards and Operating Procedures Atlanta, USA 2015 [cited 2016 April 20]. http://www.cdc.gov/diabetes/prevention/pdf/dprp-standards.pdf.